Sheba медициналық орталығы
| Израиль | Түркия | Австрия | |
| Юинг саркомасын кешенді емдеу | бастап $144,000 | бастап $30,000 | бастап $55,000 |
| Сүт безі рагында химиотерапия | бастап $22,500 | бастап $1,200 | бастап $15,000 |
| Тік ішек қатерлі ісігінде сәулелік терапия | - | бастап $7,000 | бастап $12,000 |
| Сүйекті резекциялау | - | бастап $8,000 | бастап $25,000 |
| Саркомадағы сәулелік терапия | - | бастап $3,250 | бастап $18,000 |
Клиника Ассута (Assuta) — Израильдегі ең ірі жеке медициналық орталық. Госпиталь онкология, ортопедия, нейро-, кардиохирургия және бедеулікті емдеуге маманданған. Елдегі барлық операциялардың 13% Ассутада өткізіледі, бұл оны хирургия бойынша жетекші орталық етеді.
Емдеудің сапасы мен қауіпсіздігі үшін аурухана американдық Joint Commission International аккредитациясын алды.
Әр жыл сайын Ассута желісінің дәрігерлері 92 000-нан астам операция, 685 000 диагностикалық процедура және 16 000 ЭКО циклдарын өткізеді.
Профессор Меримский Сураски медициналық орталығындағы Сүйек және жұмсақ тіндердің саркомасы бойынша Израиль ұлттық орталығын басқарады. Ол тек саркома жағдайларын емдеуге маманданған.
Доктор Ронит Эль Хасид — балалардың жілік майын трансплантациялау саласындағы жетекші маман. Ол балаларға өмірлік маңызы бар 300-ден астам осындай процедура жасаған.
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Israeli medical centers report a 5-year survival rate of 82% for localized Ewing sarcoma. Success depends on the disease stage and treatment protocols. Specialized oncology centers in Tel Aviv and Jerusalem achieve complete remission in 70% of treated cases.
Bookimed Expert Insight: Israeli oncology excellence is driven by multidisciplinary expertise at centers like Sourasky, which reports a 90% average success rate. Dr. Ofer Merimsky leads specialized bone sarcoma units there. High-volume centers often combine surgery with bone marrow transplants for pediatric cases to improve outcomes.
Patient Consensus: Patients emphasize that while public statistics are rare, Israeli multidisciplinary teams provide high confidence. They recommend comparing local protocols with international standards during initial oncology consultations.
Leading Israeli hospitals specializing in Ewing s sarcoma include Sheba Medical Center, Sourasky Medical Center, and Rambam Medical Center. These facilities typically hold Joint Commission International (JCI) accreditation. Specialized centers use precision medicine and multidisciplinary teams to treat complex bone and soft tissue tumors.
Bookimed Expert Insight: While Sheba Medical Center is globally ranked 7th for 2026, Sourasky reports a 90% oncology success rate. Patients seeking pediatric care should note that Dr. Hana Golan at Sheba and Dr. Dror Levin at Sourasky specialize specifically in pediatric sarcoma coordination. Comparing these centers is vital as Sourasky serves 400,000 patients annually while Sheba handles over 2 million, indicating different scales of resource accessibility.
Patient Consensus: Patients often emphasize the coordinated care between orthopedists and oncologists. Many note it is helpful to have a dedicated coordinator for complex pediatric treatment schedules.
Israeli oncology centers provide multi-modal treatment including high-dose chemotherapy, limb-sparing surgery, and bone marrow transplantation. Facilities like Sheba Medical Center utilize PET/CT imaging and molecular profiling to tailor protocols. Specialized units focus on pediatric cases using advanced techniques like stem cell rescue and CAR-T therapies.
Bookimed Expert Insight: While chemotherapy remains the standard, clinics like Sheba and Sourasky differentiate through volume and specialization. Dr. Boaz Liberman at Sheba focuses on functional outcomes using magnetic resonance-guided ultrasound. Sourasky reports a 90% oncology success rate with experts like Dr. Ofer Merimsky. These centers manage high patient volumes, often treating over 1,000,000 people annually.
Patient Consensus: Patients note that Israel offers faster access to experimental treatments and compassionate use drugs compared to many global waitlists. Families emphasize the importance of early genetic testing to ensure eligibility for the newest clinical trials and targeted therapies.
Ewing's sarcoma treatment in Israel typically requires a stay of 30 days for advanced procedures like bone marrow transplants. Diagnostics usually take 3 to 4 days. Complex therapy cycles or cellular treatments often extend the residency to 21 days or more for safe monitoring.
Bookimed Expert Insight: While a 30-day stay is standard for complex transplants at centers like Sheba Medical Center, patients should focus on the package inclusions. Most high-tier Israeli packages already bundle 24-hour nursing and nutritionist-led meals into that month-long stay. This significantly reduces the logistical burden during such an intensive recovery period.
Patient Consensus: Patients note it is helpful to have all-inclusive transfers and meals bundled. They often mention the peace of mind provided by having 24-hour nursing care during long hospital stays.
Follow-up surveillance for Ewing's sarcoma involves a strict schedule of imaging and blood tests to monitor for recurrence. Patients typically undergo PET-CT scans, chest X-rays, and local site imaging every three months for the first two years. These protocols ensure early detection. Israel's oncology centers provide detailed home-transition plans.
Bookimed Expert Insight: While major centers like Sheba Medical Center handle over 2 million patients yearly, the follow-up for Ewing's sarcoma is highly personalized based on the initial tumor location. For example, Dr. Iris Kventsel at Sheba specializes in pediatric bone marrow transplants, where follow-up often includes computerized bone mineralometry for long-term skeletal health. Patients should ensure their discharge papers explicitly link their surgeons and onco-hematologists for coordinated imaging reviews.
Patient Consensus: Patients emphasize the need to request a written two-to-five year surveillance schedule before leaving Israel. Many note that maintaining a personal log of scan dates is vital because coordination between different departments can vary.
Limb-salvage surgery is possible in approximately 90% of oncology cases in Israel. Surgeons prioritize saving the limb unless the tumor involves major nerves or blood vessels. Amputation is necessary only if tumor removal would result in a non-functional extremity or risk life.
Bookimed Expert Insight: Israeli specialists like Dr. Boaz Liberman often use high-volume training from Canadian and US centers to perform complex skeletal reconstructions. Sheba Medical Center uniquely offers MRgFUS technology. This allows for non-invasive treatment of certain bone lesions. This technology can preserve bone integrity before considering invasive surgery. This combination of precision imaging and surgical experience often shifts the decision toward salvage.
Patient Consensus: Patients note that pelvic Ewing sarcoma may still require amputation if nerves are involved. Many emphasize that a functional prosthesis can sometimes offer better mobility than a salvaged limb with chronic pain.
Patients traveling to Israel for Ewing's sarcoma treatment require a valid passport and often a B2 medical visa. Advanced medical preparations include translating previous scans and reports into English. Pre-arrival pathology reviews and teleconsultations with oncologists help confirm treatment readiness and avoid unnecessary delays upon landing.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center often require highly specific diagnostic benchmarks. Our data shows that top centers include comprehensive pre-transplant screenings in their packages. While some packages like Sheba's $160,000 bone marrow transplant include full diagnostics, patients should still send baseline bloodwork early. This allows the Israeli team to adjust protocols before you even board the plane.
Patient Consensus: Patients note it is vital to ship medical records ahead of time to prevent intake delays. They also emphasize that a pre-travel teleconsultation is essential for securing a treatment slot.